These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 33180672)
1. Hiding in plain sight: structure and sequence analysis reveals the importance of the antibody DE loop for antibody-antigen binding. Kelow SP; Adolf-Bryfogle J; Dunbrack RL MAbs; 2020; 12(1):1840005. PubMed ID: 33180672 [TBL] [Abstract][Full Text] [Related]
2. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain. Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181 [TBL] [Abstract][Full Text] [Related]
3. Germlining of the HIV-1 broadly neutralizing antibody domain m36. Chen W; Li W; Ying T; Wang Y; Feng Y; Dimitrov DS Antiviral Res; 2015 Apr; 116():62-6. PubMed ID: 25676867 [TBL] [Abstract][Full Text] [Related]
4. Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop. Cale EM; Gorman J; Radakovich NA; Crooks ET; Osawa K; Tong T; Li J; Nagarajan R; Ozorowski G; Ambrozak DR; Asokan M; Bailer RT; Bennici AK; Chen X; Doria-Rose NA; Druz A; Feng Y; Joyce MG; Louder MK; O'Dell S; Oliver C; Pancera M; Connors M; Hope TJ; Kepler TB; Wyatt RT; Ward AB; Georgiev IS; Kwong PD; Mascola JR; Binley JM Immunity; 2017 May; 46(5):777-791.e10. PubMed ID: 28514685 [TBL] [Abstract][Full Text] [Related]
5. A new clustering of antibody CDR loop conformations. North B; Lehmann A; Dunbrack RL J Mol Biol; 2011 Feb; 406(2):228-56. PubMed ID: 21035459 [TBL] [Abstract][Full Text] [Related]
6. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. Barrios Y; Jirholt P; Ohlin M J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640 [TBL] [Abstract][Full Text] [Related]
7. Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120. Bagley J; Dillon PJ; Rosen C; Robinson J; Sodroski J; Marasco WA Mol Immunol; 1994 Oct; 31(15):1149-60. PubMed ID: 7935503 [TBL] [Abstract][Full Text] [Related]
8. Comparative Analysis of the CDR Loops of Antigen Receptors. Wong WK; Leem J; Deane CM Front Immunol; 2019; 10():2454. PubMed ID: 31681328 [TBL] [Abstract][Full Text] [Related]
9. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design. Adolf-Bryfogle J; Kalyuzhniy O; Kubitz M; Weitzner BD; Hu X; Adachi Y; Schief WR; Dunbrack RL PLoS Comput Biol; 2018 Apr; 14(4):e1006112. PubMed ID: 29702641 [TBL] [Abstract][Full Text] [Related]
10. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework. Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785 [TBL] [Abstract][Full Text] [Related]
11. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction. Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095 [TBL] [Abstract][Full Text] [Related]
12. The diversity of H3 loops determines the antigen-binding tendencies of antibody CDR loops. Tsuchiya Y; Mizuguchi K Protein Sci; 2016 Apr; 25(4):815-25. PubMed ID: 26749247 [TBL] [Abstract][Full Text] [Related]
13. Length-independent structural similarities enrich the antibody CDR canonical class model. Nowak J; Baker T; Georges G; Kelm S; Klostermann S; Shi J; Sridharan S; Deane CM MAbs; 2016; 8(4):751-60. PubMed ID: 26963563 [TBL] [Abstract][Full Text] [Related]
14. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs. Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633 [TBL] [Abstract][Full Text] [Related]
15. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface. Kuroda D; Shirai H; Kobori M; Nakamura H Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566 [TBL] [Abstract][Full Text] [Related]
16. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin. Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142 [TBL] [Abstract][Full Text] [Related]
17. Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies. LaBranche CC; Henderson R; Hsu A; Behrens S; Chen X; Zhou T; Wiehe K; Saunders KO; Alam SM; Bonsignori M; Borgnia MJ; Sattentau QJ; Eaton A; Greene K; Gao H; Liao HX; Williams WB; Peacock J; Tang H; Perez LG; Edwards RJ; Kepler TB; Korber BT; Kwong PD; Mascola JR; Acharya P; Haynes BF; Montefiori DC PLoS Pathog; 2019 Sep; 15(9):e1008026. PubMed ID: 31527908 [TBL] [Abstract][Full Text] [Related]
18. Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization. Willis JR; Finn JA; Briney B; Sapparapu G; Singh V; King H; LaBranche CC; Montefiori DC; Meiler J; Crowe JE Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4446-51. PubMed ID: 27044078 [TBL] [Abstract][Full Text] [Related]
19. A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops. Decanniere K; Desmyter A; Lauwereys M; Ghahroudi MA; Muyldermans S; Wyns L Structure; 1999 Apr; 7(4):361-70. PubMed ID: 10196124 [TBL] [Abstract][Full Text] [Related]
20. A germline knowledge based computational approach for determining antibody complementarity determining regions. Zhao S; Lu J Mol Immunol; 2010 Jan; 47(4):694-700. PubMed ID: 19939452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]